Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Abdullah Kharbosh"'
Autor:
Khalid Al Sulaiman, Ohoud Aljuhani, Abdullah M. Alhammad, Kholoud Al Aamer, Sara Alshehri, Abdulmohsen Alhuwahmel, Abdullah Kharbosh, Areej Alshehri, Hanan Alshareef, Ibrahim Al Sulaihim, Albandari Alghamdi, Shmeylan Al Harbi, Ramesh Vishwakarma, Numan Alabdan, Yousef Alrajhi, Abdulmalik Al Katheri, Abeer A. Alenazi, Mai Alalawi, Ghassan Al Ghamdi
Publikováno v:
Saudi Pharmaceutical Journal, Vol 30, Iss 12, Pp 1748-1754 (2022)
Background: Colistin is considered a valuable and last-resort therapeutic option for MDR gram-negative bacteria. Nephrotoxicity is the most clinically pertinent adverse effect of colistin. Vivo studies suggest that administering oxidative stress-redu
Externí odkaz:
https://doaj.org/article/141586f1e6774c669d035172211621cb
Autor:
Khalid Al Sulaiman, Ohoud Aljuhani, Abdulrahman I. Al Shaya, Abdullah Kharbosh, Raed Kensara, Alhomaidi Al Guwairy, Aisha Alharbi, Rahmah Algarni, Shmeylan Al Harbi, Ramesh Vishwakarma, Ghazwa B. Korayem
Publikováno v:
Critical Care, Vol 25, Iss 1, Pp 1-8 (2021)
Abstract Background Zinc is a trace element that plays a role in stimulating innate and acquired immunity. The role of zinc in critically ill patients with COVID-19 remains unclear. This study aims to evaluate the efficacy and safety of zinc sulfate
Externí odkaz:
https://doaj.org/article/19d5ca74610a44708393596dd4f24ae9
Autor:
Khalid Al Sulaiman, Ohoud Aljuhani, Ghazwa B. Korayem, Ali F. Altebainawi, Shmeylan Al Harbi, Abdulrahman Al Shaya, Hisham A. Badreldin, Raed Kensara, Abdullah F. Alharthi, Jahad Alghamdi, Ahad Alawad, Rand Alotaibi, Abdullah Kharbosh, Hessa Al Muqati, Abdulmohsen Alhuwahmel, Mohammed Almusallam, Ghada Albarrak, Ibrahim Al Sulaihim, Bader Alanazi, Bodoor S. Al-Dosari, Ramesh Vishwakarma, Alawi S. Alsaeedi, Ghassan Al Ghamdi, Hadeel Alkofide, Hasan M. Al-Dorzi
Publikováno v:
Frontiers in Public Health, Vol 10 (2022)
BackgroundThe cardiovascular complications of Coronavirus Disease 2019 (COVID-19) may be attributed to the hyperinflammatory state leading to increased mortality in patients with COVID-19. HMG-CoA Reductase Inhibitors (statins) are known to have plei
Externí odkaz:
https://doaj.org/article/497e868d0a4c41eabcb9464903f68d69
Autor:
Khalid Al Sulaiman, Abdullah Kharbosh, Khalid Bin Salah, Thamer Alsulaiman, Norah Al Andas, Ohoud Aljuhani, Ramesh Vishwakarma
Publikováno v:
Journal of Pharmacy Practice. 36:566-571
Background: Using ursodeoxycholic acid (UDCA) in critically ill patients as adjunctive therapy for sepsis/septic shock in neonates and children is controversial, while it has not been extensively investigated in adults. This study aims to assess the
Autor:
Khalid Al Sulaiman, Ohoud Al Juhani, Abdullah Alhammad, Kholoud Al Aamer, Sara Alshehri, Abdulmohsen Alhuwahmel, Abdullah Kharbosh, Areej Alshehri, Hanan Al Shareef, Ibrahim Al Sulaihim, Albandari Alghamdi, Shmeylan Al Harbi, Numan Abdan, Abdulmalik Al Katheri, Yousef Alrajhi, Ramesh Vishwakarma
BackgroundColistin antibiotic is considered a valuable and last-resort therapeutic option for MDR gram-negative bacteria. Nephrotoxicity is the most clinically pertinent adverse effect for colistin. Vivo studies suggest that administering oxidative s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a229c1bf1f4c64d42d71e331aa7ac9e
https://doi.org/10.21203/rs.3.rs-1254017/v1
https://doi.org/10.21203/rs.3.rs-1254017/v1
Autor:
Khalid Al Sulaiman, Ohoud Aljuhani, Ghazwa B. Korayem, Ali F. Altebainawi, Shmeylan Al Harbi, Abdulrahman Al Shaya, Hisham A. Badreldin, Raed Kensara, Abdullah Al Harthi, Jahad Alghamdi, Ahad Alawad, Rand Alotaibi, Abdullah Kharbosh, Hessa Al Muqati, Abdulmohsen Alhuwahmel, Mohammed Almusallam, Ghada Albarrak, Ibrahim Al Sulaihim, Bader Alanazi, Bodoor S. Al-Dosari, Ramesh Vishwakarma, Alawi S. Alsaeedi, Ghassan Al Ghamdi, Hasan M Al-Dorzi
Background The cardiovascular complications of Severe Coronavirus Disease 2019 (COVID-19) may be attributed to the hyperinflammatory state leading to increased mortality in patients with COVID-19. Statins are known to have pleiotropic and anti-inflam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95aa4aafaf963ac55c2e8fa22f624d44
https://doi.org/10.21203/rs.3.rs-828175/v3
https://doi.org/10.21203/rs.3.rs-828175/v3
Autor:
Abdulrahman Al Shaya, Abdullah Al Harthi, Ohoud Aljuhani, Bodoor S. Al-Dosari, Ramesh Vishwakarma, Abdulmohsen Alhuwahmel, Ghazwa B. Korayem, Jahad Alghamdi, Hisham A. Badreldin, Bader Alanazi, Khalid Al Sulaiman, Ghassan Al Ghamdi, Ibrahim Al Sulaihim, Hasan M. Al-Dorzi, Ali F. Altebainawi, Mohammed Almusallam, Hessa Al Muqati, Rand Alotaibi, Shmeylan Al Harbi, Alawi S. Alsaeedi, Ahad Alawad, Raed Kensara, Abdullah Kharbosh
Purpose The complications of Severe Corona Virus Disease 2019 (COVID-19) are attributed to the overproduction of early response proinflammatory cytokines, causing a systemic hyperinflammatory state. Statins are potentially a potent adjuvant therapy i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc9bf8cfdd74f2185bc0cc97bb860231
https://doi.org/10.21203/rs.3.rs-828175/v2
https://doi.org/10.21203/rs.3.rs-828175/v2
Autor:
Ramesh Vishwakarma, Alhomaidi Al Guwairy, Raed Kensara, Khalid Al Sulaiman, Shmeylan Al Harbi, Rahmah Algarni, Aisha Alharbi, Ohoud Aljuhani, Abdulrahman Al Shaya, Abdullah Kharbosh, Ghazwa B. Korayem
Publikováno v:
Critical Care
Critical Care, Vol 25, Iss 1, Pp 1-8 (2021)
Critical Care, Vol 25, Iss 1, Pp 1-8 (2021)
Background: Zinc is a trace element that plays a role in stimulating innate and acquired immunity. The role of zinc in critically ill patients with COVID-19 remains unclear. This study aims to evaluate the efficacy and safety of zinc sulfate as adjun
Autor:
Alaa Almagthali, Sarah Al Bilal, Khalid Bin Salah, Abdullah Kharbosh, Asma Alshehri, Samia Alsohemi, Maram Abuzaid, Feras Al Harbi, Khalid Al Sulaiman, Ramesh Vishwakarma, Mohammed Al Essa, Haytham Noureldeen, Ohoud Aljuhani, Mohammed Aboudeif, Khalid Eljaaly, Ghazwa B. Korayem, Adel Alshabasy
Publikováno v:
Journal of Critical Care
Background: In COVID-19 patients, increased IL-6 levels have been associated with poor disease prognosis. The use of tocilizumab shown to be effective in treating COVID-19 with varying success. This study aims to evaluate the effectiveness and safety
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a52b351f4eb0c6d95204be94a595b4a5
https://doi.org/10.21203/rs.3.rs-526150/v2
https://doi.org/10.21203/rs.3.rs-526150/v2
Autor:
Khalid Al Sulaiman, Ohoud Al Juhani, Khalid Bin Salah, Ghazwa Koryem, Khalid Eljaaly, Mohammed Al Essa, Abdullah Kharbosh, Feras Al Harbi, Maram Abuzaid, Sarah Al Bilal, Alaa Magthali, Samia Alsohemi, Adel Alshabasy, Hyatham Albossiry, Mohammed Abodeif, Ramesh Vishwakarma
Background: In COVID-19 patients, increased IL-6 levels have been associated with poor disease prognosis. The use of tocilizumab shown to be effective in treating COVID-19 with varying success. This study aims to evaluate the effectiveness and safety
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e94626f20ea273e0657741e25999889
https://doi.org/10.21203/rs.3.rs-526150/v1
https://doi.org/10.21203/rs.3.rs-526150/v1